Investor Relations

UTILITY is a privately held pharmaceutical development company.

UTILITY has raised funds through family offices and institutional investors to execute on development and NDA preparation. At UTILITY, we are committed to providing reliable and transparent information about our business, development programs, and regulatory progress in a clear and timely manner.

 

For more information, please contact:
Tom Hadley, President and CEO
Email: tom.hadley@utilitytherapeutics.com
Phone: 973-224-7272